Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,142
Closed -$258K 90
2026
Q1
$258K Hold
2,142
0.31% 62
2025
Q4
$225K Buy
+2,142
New +$201K 0.2% 71
2025
Q2
Sell
-3,390
Closed -$304K 93
2025
Q1
$304K Hold
3,390
0.15% 86
2024
Q4
$337K Sell
3,390
-30
-0.9% -$3.09K 0.18% 81
2024
Q3
$388K Sell
3,420
-179
-5% -$21.3K 0.2% 76
2024
Q2
$446K Buy
3,599
+72
+2% +$9.27K 0.23% 69
2024
Q1
$465K Buy
3,527
+407
+13% +$50.2K 0.26% 63
2023
Q4
$340K Buy
+3,120
New +$324K 0.2% 69

Other funds holding MRK

ORBA Wealth Advisors's MRK Position: Q2 2026 in Review

ORBA Wealth Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 2,142 shares — an estimated $258K sold.

ORBA Wealth Advisors first reported a position in MRK in Q4 2023 and held it in 8 quarters. The position peaked at $465K in Q1 2024. 1,598 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ORBA Wealth Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • ORBA Wealth Advisors sold 2,142 Merck shares in Q2 2026, an estimated $258K.
  • ORBA Wealth Advisors first reported a position in Merck in Q4 2023 and held it in 8 quarters.
  • ORBA Wealth Advisors's Merck position peaked at $465K in Q1 2024.
  • 1,598 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ORBA Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.